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Introduction: There is evidence for hippocampal dysfunctions in systemic lupus erythematosus
(SLE), which may contribute to neuropsychiatric impairments. However, fine structural alter-
ations of the hippocampus have not been investigated in SLE. Methods: We measured the
volume of hippocampal subfields in 18 SLE patients and 20 healthy control individuals
matched for age, gender, and education. The MRI protocol included structural T1 volumes
(Philips Achieva 3T scanner, magnetization-prepared rapid acquisition gradient echo
(MPRAGE)). For image processing, we used the neuGRID platform and the longitudinal
pipeline of FreeSurfer v6.0 with the ‘‘hipposubfields’’ flag. Results: Patients with SLE showed
reduced volumes of CA1 (Cornu Ammonis 1) and CA4-dentate gyrus subfields relative to the
control individuals. Smaller CA1 volumes were associated with worse performance on the
Addenbrooke’s Cognitive Examination. Conclusions: These preliminary results indicate a
prominent vulnerability and functional relevance of the CA1 hippocampal subfield in
SLE. Lupus (2017) 26, 1378–1382.
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Introduction
Several studies reported neuropsychiatric manifest-
ations in patients with systemic lupus erythemato-
sus (SLE). The American College of Rheumatology
(ACR) published a case deﬁnition and recommen-
dations for neuropsychiatric SLE in which 19
diﬀerent symptoms and syndromes were included.1
The prevalence of neuropsychiatric manifestations
in SLE patients may be as high as 80% when the
ACR nomenclature is considered. Regarding
cognitive dysfunctions, most studies suggest a
cross-sectional frequency of around 20% in SLE
even when no other prominent neuropsychiatric
symptoms are observable.2–5
From a broad range of cognitive dysfunctions,
memory impairment is often reported in patients
with SLE, which is consistent with hippocampal
changes associated with the disease.5,6 There is
structural neuroimaging evidence for reduced
volumes of the hippocampal formation, corpus cal-
losum, cerebellum, cerebral cortex, and amygdala
in SLE.7–12 Functional neuroimaging studies
demonstrated altered metabolism and functional
connectivity in the prefrontal cortex, inferior par-
ietal cortex, hippocampus, and anterior cingulate
cortex of patients with SLE.5,13,14
The hippocampal formation is not a homoge-
neous structure: It consists of several histologically
distinguishable modules, such as Cornu Ammonis
(CA) regions, dentate gyrus (DG), presubiculum,
and subiculum. These regions of the hippocampus
are associated with diﬀerent functions (e.g. memory
encoding and retrieval) and may be speciﬁcally
disrupted in various diseases.15,16 Despite the sig-
niﬁcance of this structural and functional special-
ization, to our knowledge, no studies have been
conducted to elucidate possible subﬁeld-speciﬁc
hippocampal alterations in SLE. The aim of the
present study was to examine the possibility that
circumscribed subﬁelds of the hippocampus show
volumetric alterations in SLE.
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Methods
Participants
We recruited 18 female SLE patients who met the
criteria of the ACR.1 There was no history of neuro-
psychiatric manifestations. The patients were com-
pared with 20 healthy volunteers matched for age,
education, and gender. Cognitive and neuropsycho-
logical assessment included the Mini-Mental State
Examination (MMSE)17 and the Addenbrooke’s
Cognitive Assessment (ACE).18 The clinical state of
the patients was characterized by the Systemic Lupus
Disease Activity Index (SLEDAI)19 and the Systemic
Lupus International Collaborating Clinic/ACR
damage index (SLICC/ACR DI).20 All patients
received steroid anti-inﬂammatory drugs (prednisol-
one, methylprednisolone), and six patients also
received disease-modifying antirheumatoid drugs
(methotrexate, leﬂunomide, and chloroquine). The
clinical and demographic data are shown in Table 1.
All patients provided written informed consent
and the study was conducted in accordance with
the Declaration of Helsinki. The procedure was
approved by the national ethics board (ETT-
TUKEB).
Structural magnetic resonance imaging
We followed the protocol of Marizzoni et al.,21
which revealed longitudinal reproducibility of auto-
mated volumetric measurements of hippocampal
subﬁelds in several European centers. The protocol
included structural T1 volumes (Philips Achieva 3T
scanner, magnetization-prepared rapid acquisition
gradient echo (MPRAGE), three-dimensional
sagittal acquisition, ﬁeld of view¼ 240mm,
240 256 matrix, inversion time¼ 900ms, echo
time (shortest)¼ 3.6ms, ﬂip angle: 8 degrees, no
fat suppression, partial k space, no averages, acqui-
sition time: 4 minutes and 17 seconds, acceleration
factor: 1).
We used the neuGRID platform and the longi-
tudinal pipeline of FreeSurfer v6.0 with the ‘‘hip-
posubﬁelds’’ ﬂag, which is a newer version of the
software compared to that used by Marizzoni
et al.21 No manual adjustments were applied. We
measured the volumes of CA1, CA2–CA3, CA4-
DG), subiculum, and presubiculum. This validated
method is widely used in clinical research.21,22 The
exploratory analyses did not show signiﬁcant dif-
ferences in left and right hippocampal subﬁelds.
Therefore, the data were averaged across hemi-
spheres to reduce the number of variables in our
small sample. Hippocampal subﬁeld volumes were
adjusted by using the total intracranial volume.
Data analysis
STATISTICA 12 (StatSoft, Tulsa, OK, USA) soft-
ware was used for data analysis. SLE patients and
control individuals were compared with two-tailed
t-tests, corrected for multiple comparisons by using
the false discovery rate (FDR) method. Eﬀect size
values (Cohen’s d) were also calculated. Pearson’s
product moment correlation coeﬃcients were calcu-
lated between hippocampal subﬁeld volumes and
cognitive measures. We used partial correlations
to control for age, gender, and education. The
level of statistical signiﬁcance was set at
alpha< 0.05.
Results
Table 2 shows the hippocampal subﬁeld volumes.
There were signiﬁcant volume reductions in SLE
patients relative to control individuals in CA1 and
CA4-DG subregions (Figure 1). The remaining hip-
pocampal subﬁeld did not show volumetric alter-
ations in SLE.
SLE patients showed a mild but statistically sig-
niﬁcant cognitive impairment on the ACE scale
(Table 1). There was a signiﬁcant positive correl-
ation between ACE scores and CA1 volumes in
SLE (higher ACE scores reﬂecting better cognitive
functions were associated with larger CA1 volumes)
(r¼ 0.62, p¼ 0.005). The remaining hippocampal
subﬁelds did not correlate with the ACE scores
(0.2< rs< 0.2). MMSE was not sensitive enough
Table 1 Clinical and demographic characteristics
SLE (n¼ 18)
Control individuals
(n¼ 20)
Age (years) 43.4 (12.0) 45.0 (11.9)
Education (years) 15.5 (2.7) 14.9 (3.7)
MMSE 29.3 (1.2) 29.8 (0.6)
ACEa 91.7 (4.4) 95.4 (4.1)
Age at disease onset (years) 38.1 (12.6) –
SLEDAI 5.2 (2.6) –
SLICC/ACR DI 0.9 (1.2) –
Prednisolone equivalent
corticosteroid dose
8.3 (5.4)
Data are mean (standard deviation). SLE: systemic lupus erythemato-
sus; MMSE: Mini-Mental State Examination; ACE: Addenbrooke’s
Cognitive Assessment; SLEDAI: Systemic Lupus Disease Activity
Index; SLICC/ACR DI: Systemic Lupus International Collaborating
Clinic American College of Rheumatology damage index.
aSignificant difference between SLE patients and control individuals,
t(36)¼2.62, p¼ 0.01.
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to detect between-group diﬀerences (Table 1), and
its scores did not correlate with hippocampal vol-
umes (0.2< rs< 0.2). We found no signiﬁcant
correlations between hippocampal subﬁelds, dis-
ease duration, clinical scales, and corticosteroid
doses (0.1< rs< 0.1).
Discussion
To the best of our knowledge, this is the ﬁrst in vivo
demonstration of selective hippocampal subﬁeld
deﬁcits in SLE, namely, in the CA1 and CA4-DG
areas. Interestingly, this deﬁcit was observed in
SLE patients with relatively preserved cognitive
functions and no neuropsychiatric manifestations.
Mild deﬁcits on the ACE were associated with
smaller CA1, but not CA4-DG, volumes.
There are a couple of previous studies that
should be taken into consideration as elements of
context of our results. In a patient who died from
SLE with neuropsychiatric manifestations, Ballok
et al.23 showed reduced neuronal density in CA3
and DG, but not in CA1, which is partially consist-
ent with our in vivo ﬁndings from SLE patients
without neuropsychiatric manifestations. In a
longitudinal study including 150 patients with
SLE, Appenzeller et al.7 identiﬁed hippocampal
atrophy in 43.9% of patients, which increased to
66.7% by the end of the study. Hippocampal atro-
phy was associated with disease duration, total
corticosteroid dose, history of central nervous
system manifestations, and cognitive impairment.
It is important to note that the circumscribed hip-
pocampal volume loss described in our sample was
not related to disease duration and corticosteroid
dose, which can be explained by the small sample
size. Recent results conﬁrmed that hippocampal
volume reduction is indeed frequently diagnosed
in SLE,11 and the alteration of hippocampal
signal intensity is a useful marker to determine
patients with further progressive hippocampal
atrophy.12 However, in SLE patients without
neuropsychiatric manifestations not all studies
reported hippocampal atrophy even though the
patients showed a generalized cognitive deﬁcit.24
A possible explanation is that less severely aﬀected
SLE patients are characterized by hippocampal
subﬁeld-speciﬁc volume reductions (CA1 and
CA4-DG) as shown in the present study.
The CA1 subﬁeld has a key role in learning and
memory as the main output structure of the hippo-
campus. Most information leaves the hippocampus
via CA1 and propagates to the neocortex. Within
the hippocampus proper, CA1 is densely connected
to DG via CA3. However, CA1 also receives direct
pathways from the entorhinal cortex, which is a
gateway to the hippocampus. Therefore, CA1
receives and compares two kinds of information:
pre-processed and stored representations from the
DG-CA3 system and new information from the
entorhinal cortex.15,16 This mechanism may sup-
port the detection of a mismatch between internal
representations and new environmental stimuli
resulting in error signal processing (mismatch
between expectations and actual sensory informa-
tion) and novelty detection.25 On the other hand,
recurrent and bidirectional DG-CA3 interactions
may be linked to the sequential recall of memory
events.26 Interestingly, these hippocampal sub-
regions display distinct electrophysiological proper-
ties, which may result in diﬀerent functions in
memory and spatial navigation.27
Bartsch et al.28 recently showed that the CA1
region is especially vulnerable to many types of
metabolic and cytotoxic insults, including ischemia,
inﬂammation (limbic encephalitis), status epilepti-
cus, and transient global amnesia. Our results
extend these ﬁndings, indicating that CA1 is also
vulnerable in SLE and may speciﬁcally contribute
to cognitive impairments. The possible mechanisms
Figure 1 T1-weighted structural MRI images illustrating
FreeSurfer hippocampal subfields in a healthy control individ-
ual and a patient with SLE. Atrophy of the CA1 and CA4–DG
subfields is observable in SLE. MRI: magnetic resonance ima-
ging; SLE: systemic lupus erythematosus; CA: Cornu
Ammonis; DG: dentate gyrus; SUB: subiculum.
Table 2 Hippocampal subfield volumes (mm3)
SLE (n¼ 18)
Control individuals
(n¼ 20) t p d
CA1 281.6 (71.4) 339.1 (56.6) 2.76 0.009a 0.9
CA2-CA3 825.3 (85.3) 858.4 (74.3) 1.28 0.21 0.4
CA4-DG 483.6 (85.9) 577.7 (72.7) 3.66 0.0008a 1.2
Subiculum 571.1 (90.2) 578.0 (88.3) 0.23 0.82 0.08
Presubiculum 398.8 (91.9) 408.5 (74.6) 0.54 0.59 0.1
Data are mean (standard deviation). SLE: systemic lupus erythemato-
sus; CA: Cornu Ammonis, DG: dentate gyrus.
aSignificant differences after false discovery method corrections.
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may include compromised synaptic plasticity, anti-
bodies against the N-methyl-D-aspartate (NMDA)
receptor, and decreased long-term potentiation and
neurogenesis, which are candidate mechanisms for
neuropsychiatric manifestations associated with
chronic inﬂammatory conditions such as SLE.29,30
It is important to note that the patients in this study
did not show severe neuropsychiatric symptoms,
which indicates that structural abnormalities of
the hippocampus are present in mild cases and con-
tribute to subtle cognitive impairments.
Some limitations should be mentioned. First, the
sample size was small and, therefore, the results are
preliminary. Second, the cognitive assessment was
limited to a few testing procedures that are not
suitable for the evaluation of more speciﬁc cogni-
tive functions. In addition, depression and fatigue
must also be taken into consideration, although the
current sample did not include SLE patients with
major depressive or anxiety disorders. Future stu-
dies should investigate these issues.
In conclusion, SLE with subtle cognitive impair-
ments is associated with reduced CA1 and
DG-CA4 volumes, and CA1 atrophy is related to
cognitive dysfunctions.
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